P350 Impact of one year of treatment with elexacaftor/tezacaftor/ivacaftor on clinical outcomes in adult patients with cystic fibrosis - first experience from Croatia

Autor: Čičković, I. Lalić, Palković, T. Odobašić, Josić, L., Jelavić, M., Bambir, I., Markelić, I., Tješić-Drinković, D., Dugac, A. Vukić
Zdroj: In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S171-S172
Databáze: ScienceDirect